BiotechTube

MVA (smallpox vaccine)

Phase 1Withdrawn
0 views this week 0 watching💤 Quiet
Interest: 21/100
21
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Smallpox

Conditions

Smallpox, Atopic Dermatitis

Trial Timeline

Oct 1, 2006 → Jan 1, 2007

NCT ID
NCT00389103

About MVA (smallpox vaccine)

MVA (smallpox vaccine) is a phase 1 stage product being developed by Sanofi for Smallpox. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00389103. Target conditions include Smallpox, Atopic Dermatitis.

What happened to similar drugs?

3 of 8 similar drugs in Smallpox were approved

Approved (3) Terminated (0) Active (5)
🔄FD MVA-BNBavarian NordicPhase 3
🔄IMVAMUNE®Bavarian NordicPhase 3
🔄ACAM2000Emergent BioSolutionsPhase 3
✅Vaccination with ACAM2000Emergent BioSolutionsApproved
🔄tecovirimatSIGA TechnologiesPhase 3
✅Tecovirimat + sevelamer carbonate oral tablet + sucroferric oxyhydroxide chewable tablet + calcium acetate oral tablet + Lanthanum Carbonate Chewable TabletSIGA TechnologiesApproved
🔄TPOXXSIGA TechnologiesPhase 3

Hype Score Breakdown

Clinical
6
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00389103Phase 1Withdrawn

Competing Products

20 competing products in Smallpox

See all competitors
ProductCompanyStageHype Score
mRNA-1769ModernaPhase 2
0
Smallpox vaccine, LISTER strain, from chick embryo cellsSanofiPhase 2
35
ACAM3000 MVA VaccineSanofiPhase 1
29
MVA Smallpox vaccine + PlaceboSanofiPhase 2
35
ACAM1000 + vaccinia virus (calf lymph) smallpox vaccine: DryvaxSanofiPhase 2
27
IMVAMUNE (MVA-BN)Bavarian NordicPhase 2
32
MVA-BNBavarian NordicPhase 1
26
IMVAMUNE®Bavarian NordicPhase 2
32
LF formulation of IMVAMUNE® + FD formulation of IMVAMUNE®Bavarian NordicPhase 2
32
IMVAMUNE + IMVAMUNEBavarian NordicPhase 2
32
FD MVA-BNBavarian NordicPhase 3
37
IMVAMUNE®Bavarian NordicPhase 3
37
IMVAMUNE + IMVAMUNEBavarian NordicPhase 2
32
MVA-BN® (IMVAMUNE) + PlaceboBavarian NordicPhase 2
32
Elstree-BNBavarian NordicPhase 1
26
ACAM2000Emergent BioSolutionsPhase 3
30
VIGIVEmergent BioSolutionsPre-clinical
23
ACAM2000® smallpox vaccineEmergent BioSolutionsPre-clinical
16
BrincidofovirEmergent BioSolutionsPhase 1
19
Vaccination with ACAM2000Emergent BioSolutionsApproved
33